642 filings
Page 6 of 33
CORRESP
qsdamhwfj x6c
14 Jul 23
Correspondence with SEC
12:00am
CORRESP
ouaf bqeiis2spe4dyj
13 Jul 23
Correspondence with SEC
12:00am
8-K
mi4pu irg7
13 Jul 23
First Wave BioPharma Announces Initial Topline Results from Phase 2 SPAN Clinical Trial Investigating Enhanced Adrulipase Formulation
12:00am
CORRESP
mj5fxm5
13 Jul 23
Correspondence with SEC
12:00am
CORRESP
1jinbe3xy7pq6
11 Jul 23
Correspondence with SEC
12:00am
4
jmzvs6l20k3 epp5csli
5 Jul 23
First Wave BioPharma / Sarah Romano ownership change
4:28pm
4
lhzcm5il9oip o16izl
5 Jul 23
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:27pm
D
btl54
28 Jun 23
$431.08 k in options, sold $431.08 k, 1 investor
4:05pm
EFFECT
lvf6ug8
28 Jun 23
Notice of effectiveness
12:15am
424B3
90c3mx
27 Jun 23
Prospectus supplement
5:03pm
8-K
2w6pyasr6rpzfup8s
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
UPLOAD
yi7sppa
23 Jun 23
Letter from SEC
12:00am
CORRESP
kgm8kk0gca8hxt14 pf
23 Jun 23
Correspondence with SEC
12:00am
8-K
jwrtgx3cqsy l2b
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm
ARS
2tuqbn3cdil1rucj
15 May 23
Annual report to shareholders
5:09pm